about
Modulation of antigen-specific T-cells as immune therapy for chronic infectious diseases and cancerCrystallization and X-ray analysis of theT= 4 particle of hepatitis B capsid protein with an N-terminal extensionCD24 polymorphisms affect risk and progression of chronic hepatitis B virus infectionPartially randomized, non-blinded trial of DNA and MVA therapeutic vaccines based on hepatitis B virus surface protein for chronic HBV infection.Expression pattern of serum cytokines in hepatitis B virus infected patients with persistently normal alanine aminotransferase levels.T-cell epitope mapping of ORF2 and ORF3 proteins of human hepatitis E virus.Natural course of chronic hepatitis B is characterized by changing patterns of programmed death type-1 of CD8-positive T cells.Polymorphisms in CISH gene are associated with persistent hepatitis B virus infection in Han Chinese population.Increased numbers of CD5+CD19+CD1dhighIL-10+ Bregs, CD4+Foxp3+ Tregs, CD4+CXCR5+Foxp3+ follicular regulatory T (TFR) cells in CHB or CHC patients.Changes of Treg and Th17 cells balance in the development of acute and chronic hepatitis B virus infection.PD-1 blockage reverses immune dysfunction and hepatitis B viral persistence in a mouse animal model.Cytokine expression during chronic versus occult hepatitis B virus infection in HIV co-infected individualsInterleukin-10 promoter polymorphism predicts initial response of chronic hepatitis B to interferon alfaIncreased circulating Th17 cells after transarterial chemoembolization correlate with improved survival in stage III hepatocellular carcinoma: a prospective study.Association of TNF-α Promoter Polymorphism with HBV Associated Disease Outcome Among HBV Infected Patients from Orissa, Southern Part of East India.Relationship between serum cytokine levels and histopathological changes of liver in patients with hepatitis B.Association of polymorphism of tumor necrosis factor-alpha gene promoter region with outcome of hepatitis B virus infection.Prevalence and clinical relevance of T-helper cells, Th17 and Th1, in hepatitis B virus-related hepatocellular carcinomaThe balance between intrahepatic IL-17(+) T cells and Foxp3(+) regulatory T cells plays an important role in HBV-related end-stage liver disease.Correlation between polymorphisms of the E-selectin gene, hepatitis B virus DNA copies, pre-S1 antigen and clinical outcomes during chronic hepatitis B.Ubiquitin conjugation of hepatitis B virus core antigen DNA vaccine leads to enhanced cell-mediated immune response in BALB/c mice.Regulatory T cells and IL-17(+) T helper cells enhanced in patients with chronic hepatitis B virus infection.Association of -238G/A polymorphism of tumor necrosis factor-alpha gene promoter region with outcomes of hepatitis B virus infection in Chinese Han populationHuman Cytotoxic T Lymphocyte-Mediated Acute Liver Failure and Rescue by Immunoglobulin in Human Hepatocyte Transplant TK-NOG MiceLack of Ser267Phe variant of sodium taurocholate cotransporting polypeptide among Moroccans regardless of hepatitis B virus infection status.Prevention of liver tumor formation in woodchucks with established hepatocellular carcinoma by treatment with cationic liposome-DNA complexesEvaluation of Interleukin-10 Levels in Patients Diagnosed with Chronic HepatitisA Study on Genetic Association of Interleukin-16 Single Nucleotide Polymorphism (rs1131445) With Chronic Hepatitis B Virus Infection in Iranian PatientsCorrelation between TH1 response standard cytokines as biomarkers in patients with the delta virus in the western Brazilian AmazonSerum Interleukin (IL)-9 and IL-10, but not T-Helper 9 (Th9) Cells, are Associated With Survival of Patients With Acute-on-Chronic Hepatitis B Liver FailureNetwork Signatures of IgG Immune Repertoires in Hepatitis B Associated Chronic Infection and Vaccination Responses.Human leukocyte antigen class II association with spontaneous recovery from hepatitis B virus infection in Koreans: analysis at the haplotype levelRestoring the Treg cell to Th17 cell ratio may alleviate HBV-related acute-on-chronic liver failure.CD4+ CD25+ regulatory T cells: a therapeutic target for liver diseases.Overexpression of Fc receptor-like 1 associated with B-cell activation during hepatitis B virus infectionTreatment of hepatitis B virus-infected patients: utility of therapeutic recommendations in developing countries.Host immunity influences disease progression and antiviral efficacy in humans infected with hepatitis B virus.Hepatitis B virus genotyping: is the time ripe for routine clinical use?The underlying mechanisms for the "isolated positivity for the hepatitis B surface antigen (HBsAg)" serological profile.The underlying mechanisms for the "simultaneous HBsAg and anti-HBs serological profile".
P2860
Q27022761-A15B245A-37FC-4F38-B470-F453FEDED1B7Q27646937-AD072BE9-1ED5-4DE9-9EC7-5C2FE80E3A30Q28252325-1B22F5E1-7AF6-4092-AE6D-2650DE33AA9CQ28742762-CF211606-260A-47CC-BFA3-74BBD1C8C4F5Q31126611-E205A32A-312E-4EE0-8257-3D8B5A53CC6DQ33279839-1C9B2314-68E7-4E85-9444-66F74CC0A945Q33629455-FB7A9F64-FEDF-4B91-8DFB-28A80BA6C67CQ33806855-1A386AFB-BEB2-44E0-852C-8A7E750E99DDQ34235321-F4333132-C785-4822-ACE2-58B258A7A161Q34252890-04B6EA87-F985-43CE-8990-2F74A344B9FEQ34325908-8E8CA46A-6739-42E8-8CDE-A573DCB1A61CQ34540287-0DDEC025-87D8-4880-955A-1D170049B7FFQ34556199-419CBDDD-2C6B-477C-969B-454B30917579Q34658445-E86BC465-82FA-418D-A229-EB231C926BECQ34825656-BC96A1D3-BE31-4ED7-893E-6F9095D682B1Q35045622-CA74E8D6-0169-418D-A3C8-0DE70D31F5F8Q35059739-42863B9C-32FB-41AA-9497-6F2C20FF868DQ35175019-0CA03114-EAAA-490C-858C-ECB53DA92E8BQ35221884-AF956679-B7B2-4E71-AD65-639CC43CED49Q35481633-499C421D-DB9A-4204-A612-36D77E22C44AQ35582436-9F63CB05-4351-4246-9437-B6F599396C05Q35959215-83AF8E2A-A4C9-43A8-8F8A-46A1826729DAQ36065985-29963481-BCC5-4F4A-B7A5-01D188AEF5D0Q36080854-2450E7B5-127E-42FA-8E28-4383D68584E1Q36261626-F74991F5-7330-40F2-8B34-D6D7329CDE71Q36298758-29437E72-D440-4864-A106-0DD5B953E1F7Q36418044-A4E2C061-9A85-4E1B-84B8-56D0AB4BD6E9Q36528557-792777E9-7100-49E9-A443-E205CE5405E5Q36793890-C71B3361-7059-4036-920F-20928E7BE71AQ36838051-0EFF69CB-EC52-4567-BF3C-C5E6894F93C0Q36934124-11461791-ED00-4E15-8A54-2477A788DEB9Q36966008-0716F6CF-F0CD-4B7A-B6F1-76E9D584685BQ37009273-8FFE8AFD-04BD-4681-8F92-F56000FA6583Q37082777-1676D20F-3BA4-4878-8152-5BC037D7682EQ37371002-FA8EB78A-90DE-4C98-AB81-0FE89F271A15Q37508051-10ACC987-4CE2-4601-B5DA-96CBD10B31E0Q37611853-56957CE2-321B-44FD-9468-BC5606932B08Q37613150-515A66A1-77F6-43BE-8B00-EAB79EBB9053Q37748557-F2554610-52D2-4D1F-A295-10F0ADF82DD8Q37864136-8032B3E7-1E35-4FD3-A4DF-1A444BEC8778
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Immunology of hepatitis B infection.
@ast
Immunology of hepatitis B infection.
@en
Immunology of hepatitis B infection.
@nl
type
label
Immunology of hepatitis B infection.
@ast
Immunology of hepatitis B infection.
@en
Immunology of hepatitis B infection.
@nl
prefLabel
Immunology of hepatitis B infection.
@ast
Immunology of hepatitis B infection.
@en
Immunology of hepatitis B infection.
@nl
P1476
Immunology of hepatitis B infection.
@en
P2093
Gerd R Pape
Maria-Christina Jung
P356
10.1016/S1473-3099(01)00172-4
P577
2002-01-01T00:00:00Z